Avanos Medical Inc.

26.76+0.1800+0.68%Vol 315.71K1Y Perf -31.55%
Jun 27th, 2022 16:00 DELAYED
BID10.72 ASK42.84
Open26.84 Previous Close26.58
Pre-Market- After-Market26.76
 - -  - -%
Target Price
39.40 
Analyst Rating
Hold 2.74
Potential %
47.23 
Finscreener Ranking
★★     45.61
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
★★     47.48
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
★★+     50.02
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Price Range Ratio 52W %
15.32 
Earnings Rating
Buy
Market Cap1.27B 
Earnings Date
2nd Aug 2022
Alpha-0.01 Standard Deviation0.11
Beta0.87 

Today's Price Range

26.5027.01

52W Range

24.5439.03

5 Year PE Ratio Range

-50.8060.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
6.36%
1 Month
-6.76%
3 Months
-20.57%
6 Months
-21.69%
1 Year
-31.55%
3 Years
-38.64%
5 Years
-34.07%
10 Years
-

TickerPriceChg.Chg.%
AVNS26.760.18000.68
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Financial StrengthValueIndustryS&P 500US Markets
1.70
2.90
0.19
0.25
8.10
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
49.90
4.00
9.20
-3.90
2.32
RevenueValueIndustryS&P 500US Markets
761.30M
16.09
3.71
-6.18
Earnings HistoryEstimateReportedSurprise %
Q01 20220.240.268.33
Q04 20210.400.4615.00
Q03 20210.270.25-7.41
Q02 20210.230.21-8.70
Q01 20210.180.2327.78
Q04 20200.220.2827.27
Q03 20200.140.2150.00
Q02 2020-0.080.13262.50
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.380.00-
9/2022 QR0.450.00-
12/2022 FY1.671.21Positive
12/2023 FY2.000.50Positive
Next Report Date2nd Aug 2022
Estimated EPS Next Report0.38
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume315.71K
Shares Outstanding47.32K
Shares Float34.25M
Trades Count5.48K
Dollar Volume8.45M
Avg. Volume264.04K
Avg. Weekly Volume291.89K
Avg. Monthly Volume239.84K
Avg. Quarterly Volume260.39K

Avanos Medical Inc. (NYSE: AVNS) stock closed at 26.76 per share at the end of the most recent trading day (a 0.68% change compared to the prior day closing price) with a volume of 315.71K shares and market capitalization of 1.27B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 5380 people. Avanos Medical Inc. CEO is Joseph F. Woody.

The one-year performance of Avanos Medical Inc. stock is -31.55%, while year-to-date (YTD) performance is -22.82%. AVNS stock has a five-year performance of -34.07%. Its 52-week range is between 24.54 and 39.03, which gives AVNS stock a 52-week price range ratio of 15.32%

Avanos Medical Inc. currently has a PE ratio of 69.90, a price-to-book (PB) ratio of 1.00, a price-to-sale (PS) ratio of 1.66, a price to cashflow ratio of 14.00, a PEG ratio of 2.32, a ROA of 1.12%, a ROC of 1.39% and a ROE of 1.53%. The company’s profit margin is 2.32%, its EBITDA margin is 9.20%, and its revenue ttm is $761.30 Million , which makes it $16.09 revenue per share.

Of the last four earnings reports from Avanos Medical Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.38 for the next earnings report. Avanos Medical Inc.’s next earnings report date is 02nd Aug 2022.

The consensus rating of Wall Street analysts for Avanos Medical Inc. is Hold (2.74), with a target price of $39.4, which is +47.23% compared to the current price. The earnings rating for Avanos Medical Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avanos Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avanos Medical Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 7.19, ATR14 : 0.92, CCI20 : -29.26, Chaikin Money Flow : 0.03, MACD : -0.75, Money Flow Index : 47.00, ROC : -6.11, RSI : 47.67, STOCH (14,3) : 52.85, STOCH RSI : 1.00, UO : 49.62, Williams %R : -47.15), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avanos Medical Inc. in the last 12-months were: Patrick J. O'Leary (Buy at a value of $158 143)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (60.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Sell
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.74
Hold
2.74
Hold
2.74

Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

CEO: Joseph F. Woody

Telephone: +1 844 428-2667

Address: 5405 Windward Parkway, Alpharetta 30004, GA, US

Number of employees: 5 380

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

74%26%

Bearish Bullish

77%23%

TipRanks News for AVNS

Fri, 03 Jun 2022 04:35 GMT Avanos Medical (AVNS) Receives a Hold from JMP Securities

- TipRanks. All rights reserved.

Mon, 07 Mar 2022 20:47 GMT Avanos Medical (AVNS) Gets a Hold Rating from JMP Securities

- TipRanks. All rights reserved.

News

Stocktwits